Peter E. Valk

4.9k total citations
46 papers, 3.6k citations indexed

About

Peter E. Valk is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Peter E. Valk has authored 46 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Radiology, Nuclear Medicine and Imaging, 22 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in Peter E. Valk's work include Medical Imaging Techniques and Applications (22 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Peter E. Valk is often cited by papers focused on Medical Imaging Techniques and Applications (22 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Peter E. Valk collaborates with scholars based in United States, Australia and United Kingdom. Peter E. Valk's co-authors include W.P. Dillon, Thomas R. Pounds, Thomas F. Budinger, Donald M. Hopkins, Dale L. Bailey, David W. Townsend, Michael D. Prados, Werner Doyle, Philip H. Gutin and Victor A. Levin and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer.

In The Last Decade

Peter E. Valk

46 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter E. Valk United States 27 2.3k 1.5k 528 464 307 46 3.6k
Christiaan Schiepers United States 36 3.1k 1.4× 1.5k 1.0× 616 1.2× 930 2.0× 431 1.4× 72 4.7k
Kenneth Zasadny United States 35 3.8k 1.7× 1.3k 0.8× 403 0.8× 1.1k 2.4× 564 1.8× 56 5.7k
Matthias Weckesser Germany 33 2.0k 0.9× 1.6k 1.0× 613 1.2× 624 1.3× 368 1.2× 148 4.0k
David L. Buckley United Kingdom 46 7.0k 3.1× 1.4k 0.9× 508 1.0× 321 0.7× 435 1.4× 132 8.4k
G. van Kaick Germany 44 3.7k 1.6× 1.7k 1.1× 667 1.3× 742 1.6× 534 1.7× 251 6.3k
Tohru Shiga Japan 32 1.7k 0.8× 905 0.6× 450 0.9× 256 0.6× 549 1.8× 181 3.7k
Heinz‐Peter Schlemmer Germany 36 3.7k 1.6× 1.5k 1.0× 696 1.3× 302 0.7× 130 0.4× 243 5.4k
Hendrik Everaert Belgium 32 1.5k 0.7× 1.0k 0.7× 400 0.8× 1.3k 2.7× 295 1.0× 137 3.4k
Edward F. Jackson United States 36 1.9k 0.8× 879 0.6× 875 1.7× 457 1.0× 386 1.3× 121 4.7k
Hiroaki Hoshi Japan 32 1.5k 0.7× 1.1k 0.7× 319 0.6× 320 0.7× 104 0.3× 253 3.5k

Countries citing papers authored by Peter E. Valk

Since Specialization
Citations

This map shows the geographic impact of Peter E. Valk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Valk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Valk more than expected).

Fields of papers citing papers by Peter E. Valk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Valk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Valk. The network helps show where Peter E. Valk may publish in the future.

Co-authorship network of co-authors of Peter E. Valk

This figure shows the co-authorship network connecting the top 25 collaborators of Peter E. Valk. A scholar is included among the top collaborators of Peter E. Valk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter E. Valk. Peter E. Valk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Talbot, Peter S., Peter E. Valk, D.W. Townsend, et al.. (2003). Molecular Imaging in Psychiatric Disorders. Research Explorer (The University of Manchester). 2 indexed citations
2.
Valk, Peter E., et al.. (2002). Positron emission tomography imaging in melanoma and lymphoma. Seminars in Roentgenology. 37(2). 129–139. 6 indexed citations
3.
Silverman, Daniel, et al.. (2002). Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients.. PubMed. 43(3). 325–9. 84 indexed citations
4.
Seltzer, Marc, C Schiepers, Daniel Silverman, et al.. (2001). Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective.. PubMed. 42(4). 586–90. 90 indexed citations
5.
Yap, C., Marc Seltzer, Christiaan Schiepers, et al.. (2001). Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective.. PubMed. 42(9). 1334–7. 87 indexed citations
6.
Roberts, Peter, et al.. (2000). Factors associated with false-positive staging of lung cancer by positron emission tomography. The Annals of Thoracic Surgery. 70(4). 1154–1159. 141 indexed citations
7.
Valk, Peter E.. (1999). Whole-Body PET Imaging With [18F]Fluorodeoxyglucose in Management of Recurrent Colorectal Cancer. Archives of Surgery. 134(5). 503–511. 204 indexed citations
8.
Lowe, Val J., James W. Fletcher, Lisa S. Gobar, et al.. (1998). Prospective investigation of positron emission tomography in lung nodules.. Journal of Clinical Oncology. 16(3). 1075–1084. 407 indexed citations
9.
Gambhir, Sanjiv S., James E. Shepherd, Binita Shah, et al.. (1998). Analytical decision model for the cost-effective management of solitary pulmonary nodules.. Journal of Clinical Oncology. 16(6). 2113–2125. 152 indexed citations
10.
Barker, Fred G., Susan M. Chang, Peter E. Valk, Thomas R. Pounds, & Michael D. Prados. (1997). 18‐fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer. 79(1). 115–126. 7 indexed citations
11.
Valk, Peter E., et al.. (1996). Cost-effectiveness of PET imaging in clinical oncology. Nuclear Medicine and Biology. 23(6). 737–743. 138 indexed citations
12.
Valk, Peter E., et al.. (1993). High-resolution (2.6-mm) PET in partial complex epilepsy associated with mesial temporal sclerosis.. Radiology. 186(1). 55–58. 27 indexed citations
13.
Lo, Eng H., Robert L. DeLaPaz, Kenneth A. Frankel, et al.. (1991). MRI and PET of delayed heavy-ion radiation injury in the rabbit brain. International Journal of Radiation Oncology*Biology*Physics. 20(4). 689–696. 31 indexed citations
14.
Valk, Peter E. & W.P. Dillon. (1991). Radiation injury of the brain.. American Journal of Neuroradiology. 12(1). 45–62. 247 indexed citations
15.
Lo, Eng H., Kenneth A. Frankel, Robert L. DeLaPaz, et al.. (1989). Cerebrovascular and metabolic perturbations in delayed heavy charged particle radiation injury. Brain Research. 504(1). 168–172. 19 indexed citations
16.
Valk, Peter E., Thomas F. Budinger, Victor A. Levin, et al.. (1988). PET of malignant cerebral tumors after interstitial brachytherapy. Journal of neurosurgery. 69(6). 830–838. 170 indexed citations
17.
Valk, Peter E.. (1984). Muscle Localization of Tc-99m MDP After Exertion. Clinical Nuclear Medicine. 9(9). 493–494. 19 indexed citations
18.
McRae, James, Peter Hambright, Peter E. Valk, & Alan J. Bearden. (1976). Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.. PubMed. 17(3). 208–11. 20 indexed citations
19.
Hambright, Peter, et al.. (1975). Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.. PubMed. 16(6). 478–82. 32 indexed citations
20.
Valk, Peter E., et al.. (1972). Alteration of 99m Tc red blood cells.. PubMed. 13(6). 399–400. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026